"Global Demand Outlook for Executive Summary Antisense Oligonucleotide for Neuromuscular Disorders Market Size and Share The global antisense oligonucleotide for neuromuscular disorders market size was valued at USD 2.03 billion in 2024 and is expected to reach USD 4.87 billion by 2032, at a CAGR of 11.50% during the forecast period This Antisense...

Market Overview The Nicotinamide Adenine Dinucleotide (NAD) Market includes NAD, its precursors (such as NMN and NR), and NAD-boosting formulations used in therapeutic, nutraceutical, and research applications. NAD levels naturally decline with age, leading to reduced cellular energy production, impaired DNA repair, and increased oxidative stress, which has driven growing interest in NAD...

NEWARK, Del., Jun. 02, 2026 — The global Nucleotide Market is expected to witness sustained growth over the next decade, with market value projected to increase from USD 715.2 million in 2025 to USD 1,301.3 million by 2035, registering a CAGR of 6.1% during the forecast period, according to Future Market Insights (FMI). The increasing adoption of nucleotides across pharmaceutical...

NEWARK, Del., Jun. 02, 2026 — The global Nucleotide Market is expected to witness sustained growth over the next decade, with market value projected to increase from USD 715.2 million in 2025 to USD 1,301.3 million by 2035, registering a CAGR of 6.1% during the forecast period, according to Future Market Insights (FMI). The increasing adoption of nucleotides across pharmaceutical...